Restricted accessLetterFirst published online 2014-1
Implanted Central Venous Access Ports for Therapeutic Phlebotomy in Patients with HFE Hemochromatosis and other Non-thalassemia Iron Overload Disorders
DavisB.A., PorterJ.B.Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia. Blood.2000; 95(4): 1229–1236.
4.
BernM.M., LokichJ.J., WallachS.R.Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med.1990; 112(6): 423–428.
5.
HeiblC., TrommetV., BurgstallerS.Complications associated with the use of Port-a-Caths in patients with malignant or haematological disease: a single-centre prospective analysis. Eur J Cancer Care (Engl).2010; 19(5): 676–681.
